Patients Discontinuing Anti-Obesity Medications Gain Back Weight Four Times Faster Compared to Those on Conventional Diets

A recent study indicates that people who discontinue popular GLP-1 drugs like semaglutide or tirzepatide can put back on reduced body mass far faster than those who halt conventional lifestyle plans.

Published data in a leading medical journal demonstrates that while obese individuals frequently drop substantial amounts of their body weight while undergoing treatment, the weight comes back at an estimated rate of nearly a kilo each month after stopping.

"Individuals buying these medications must be cognizant of the danger of fast weight regain when the medication is stopped," warns expert Dr. Susan Jebb.

This pace of recovery means a return to starting mass in about one and a half years.

Comparing Approaches

The analysis, which reviewed 37 of trials involving over 9,000 of participants, contrasted the results of these new drugs with conventional dieting.

The team emphasize that people who lose weight through diet and exercise generally experience a less rapid creep back—around 100 grams monthly—once they finish.

Understanding the Quick Rebound

Experts suggest the mode of action of the drugs accounts for the accelerated weight return.

The injections mimic a body's own chemical called GLP-1, which moderates hunger.

"Artificially providing the hormone levels far above than normal could lead to the system to produce less of its endogenous GLP-1, and could diminish sensitivity to its actions," said Dr. Adam Collins, a dietetics researcher.

"Discontinuation of this GLP-1 'fix' leads to appetite is unsuppressed, making excessive eating a significant risk."

A Lifelong Issue?

Health authorities recommend the jabs for people with obesity-related medical conditions, alongside recommended lifestyle changes.

Professionals say that, given the significant potential of weight regain, the treatment should be considered life-long.

This perspective is supported by drug manufacturers, who note that the findings "highlight the long-term character of obesity," comparing it to managing conditions like hypertension.

User Experiences

People who have come off the jabs describe a powerful return of cravings.

"It felt as if a trigger flipping and I was suddenly starving," described one woman.

The struggle is compounded if patients have not developed permanent lifestyle or habit changes during therapy.

Growing Interest

Figures indicate that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with demand remaining high.

• Use is more common among women than males.
• The middle-aged demographic shows the highest usage rates.
• A large proportion access the drugs through private healthcare rather than public health services.

Finally, clinicians emphasize that while these medications are powerful tools for shedding pounds, they are not a standalone fix and long-term success hinges on integrated lifestyle changes.